
CODEXIS, INC.
Nasdaq · Industrial Organic Chemicals
Company Overview
A concise company profile alongside the latest public filing activity.
Codexis develops engineered enzymes using its proprietary protein engineering technology for use in pharmaceutical manufacturing, food production, and other industrial and life sciences applications. It sells biocatalysts and related products to pharmaceutical and other manufacturers to improve chemical processes.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Erbez GeorgiaSee Remarks | Sell | $9K | 6,335at $1.36 | Oct 12, 2026 |
| MOORE ALISONPresident and CEO | Sell | $9K | 6,335at $1.36 | Oct 12, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable CDXS activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.